Research is being conducted on the efficiency of combined antiviral therapy, particularly in challenging cases such as covid-19 in immunocompromised patients. The broader context of antiviral drug development and treatment strategies is also being explored, including treatments for other diseases like mpox and influenza. Various studies and reviews are examining the efficacy and optimization of different antiviral therapies and methods for determining their presence in pharmaceutical formulations.